Results
1
1 companies
argenx
Market Cap: €33.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€553.20
7D
-5.9%
1Y
13.2%
